Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors
marketwatch.com
news
2022-05-27 20:45:00

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP, -1.37% slid 1.37% to $0.30 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP, +3.33% rising 3.33% to 12,131.13 and the Dow Jones Industrial Average DJIA, +1.76% rising 1.76% to 33,212.96. This was the stock's sixth consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $1.99 short of its 52-week high ($2.29), which the company reached on June 9th. The stock underperformed when compared to some of its competitors Friday, as Fate Therapeutics Inc.
